On November 13, Quantinuum fell 5.26% in Regular Trading, trading at $35.52 per share, with turnover of $8.94 million.
The move coincided with continued market digestion of multiple analyst price-target reductions following the company’s latest quarterly report, reinforcing pressure on valuation expectations.
After reporting third-quarter revenue of $9.1 million, above consensus, and raising full-year revenue guidance to $31 million-$34 million from $28 million-$32 million, analysts still lowered targets. The latest public figures show UBS cut its target to $50 from $93, while Mizuho, Needham, and Jefferies lowered theirs to $70, $60, and $65, respectively. Although at least one firm initiated coverage with a $60 target, the broader reset in targets appears to be weighing on shares.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments